Description
TenatoprazoleisaninhibitoroftheH+/K+ATPasethatpreventsgastricacidsecretion,exhibitingantacidactivity.
TenatoprazoleisaninhibitoroftheH+/K+ATPasethatpreventsgastricacidsecretion,exhibitingantacidactivity.
| CasNo. | 113712-98-4 |
|---|---|
| Purity | ≥98% |
| Formula | C16H18N4O3S |
| FormulaWt. | 346.41 |
| ChemicalName | 5-Methoxy-2-{[(4-Methoxy-3,5-Dimethyl-2-pyridinyl)methyl]sulphinyl}-1H-imidazo[4,5-b]pyridine |
| IUPACName | 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine |
| Synonym | Protop;Ulsacare |
| MeltingPoint | 173-175°C |
| Solubility | Solubleindichlormethane. |
| Appearance | Whiteoroff-whitepowder |
| StoreTemp | 4°C |
|---|---|
| ShipTemp | Ambient |
| MSDS | T1754MSDSPDF |
|---|---|
| InfoSheet | T1754InfoSheetPDF |
LiH,MengL,LiuF,etal.H+/K+-ATPaseinhibitors:apatentreview.ExpertOpinTherPat.2013Jan;23(1):99-111.PMID:23205582.
ShinJM,HomerinM,DomagalaF,etal.CharacterizationoftheinhibitoryactivityoftenatoprazoleonthegastricH+,K+-ATPaseinvitroandinvivo.BiochemPharmacol.2006Mar14;71(6):837-49.PMID:16405921.